Cannabidiol

10 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Cannabidiol
Treatment and conditionWhere it standsTrials
Cannabidiol for drug resistant epilepsyPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cannabidiol for epilepsies, myoclonicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)10
Cannabidiol for epilepsyPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Cannabidiol for epilepsy, absenceTrials ended early, as of 19 Nov 2026 (not yet checked by a person)2
Cannabidiol for lennox gastaut syndromePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)10
Cannabidiol for liver cirrhosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cannabidiol for marijuana abusePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Cannabidiol for psychotic disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Cannabidiol for seizuresPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)7
Cannabidiol for spasms, infantilePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3